Skip to content
2000
image of A Comprehensive Review on the Chinese Herbal Medicine Quzhiqiao

Abstract

Quzhiqiao is a Chinese herbal medicine widely used in Zhejiang Province of China, which originates from the cultivar ‘Changshanhuyou’, named Changshanhuyou in Chinese. ‘Changshanhuyou’ is a botanical variety of L., which is obtained after long-term domestication. It belongs to the Rutaceae family and mainly grows in Changshan County, Zhejiang Province, China. Quzhiqiao is an authentic Chinese medicinal material in the Zhejiang area with various pharmacological and curative effects. A comprehensive review and in-depth analysis of scientific literature on Quzhiqiao was conducted, utilizing diverse electronic databases and additional sources. This review provides a comprehensive overview of its chemical components, standardized quality control, pharmacological activity, and mechanism of action, which also outlines future perspectives, highlighting the necessity for further research for harnessing the potential of the therapeutic use of Quzhiqiao.

Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155353712241008060527
2024-12-06
2025-05-07
Loading full text...

Full text loading...

References

  1. Yang B. Wang L. Wang M. General situation of Changshanhuyou Quzhiqiao industry development. Zhejiang Ganju 2019 36 7 9
    [Google Scholar]
  2. Jiang B. Ding H. Wang Y. Wu Y. Qian K. Pharmacological Research Progress of Fructus Aurantii. Yunnan J Tradit Chin Med Mater Med 2022 43 70 75
    [Google Scholar]
  3. ZheJiang Food and Medical Products Administration Zhejiang Province traditional Chinese medicine processing standards. Beijing China Medical Science Press 2016
    [Google Scholar]
  4. Guo Z. Zhao W. Qi Y. Li W. Description of monograph changes in Zhejiang province of processing chinese crud drugs 2015 edition. Chin J Mod Appl Pharm 2016 33 790 792
    [Google Scholar]
  5. Zhang Q. Song W. Tao G. Li Q. Wang L. Huang W. Gao L. Yin L. Ye Y. Comparison of chemical compositions and antioxidant activities for the immature fruits of Citrus changshan-huyou Y.B. Chang and Citrus aurantium L. Molecules 2023 28 13 5057 10.3390/molecules28135057 37446717
    [Google Scholar]
  6. Wei X. Jing J. Huang R. Zhou T. Wu L. Ou G. Wu Y. Hu J. Zhu W. Wu Y. Li Y. Zhang S. You Z. QFAE-nB alleviates pulmonary fibrosis by inhibiting the STING pathway in mice. J. Ethnopharmacol. 2024 319 Pt 2 117295 10.1016/j.jep.2023.117295 37806536
    [Google Scholar]
  7. Ying Y. Wan H. Zhao X. Yu L. He Y. Jin W. Pharmacokinetic-pharmacodynamic modeling of the antioxidant activity of quzhou fructus aurantii decoction in a rat model of hyperlipidemia. Biomed. Pharmacother. 2020 131 110646 10.1016/j.biopha.2020.110646 32942150
    [Google Scholar]
  8. Gao L. Zhang Y.L. Wu Y. Shao J. Zhang H. Shao Y. Xu Y. Jiang J. Study on the mechanism of the flavonoids from the new “Zhe Eight Flavors” Quzhou Fructus Aurantii against hepatocellular carcinoma based on network pharmacology. Chin J Mod Appl Pharm 2024 41 166 176
    [Google Scholar]
  9. Chen Z.Y. Li J.S. Jiang J.P. Yan M.X. He B.H. Effect of pure total flavonoids from citrus on hepatic SIRT1/PGC-1α pathway in mice with NASH. Zhongguo Zhongyao Zazhi 2014 39 1 100 105 24754177
    [Google Scholar]
  10. Wang X. Wang S. Fang Y. Hu Z. Zhong S. Lou L. Study on the hypoglycemic activity of different components of quzhiqiao in vitro and analysis of four flavonoids. Chin. J. Mod. Appl. Pharm. 2017 34 1418 1423
    [Google Scholar]
  11. Ye A. Jiang J. Li R. Jin L. Wu X. Wang J. Study on hypolipidemic effect of pure total flavonoids from Qu Aurantii Fructus on golden hamsters of hyperlipidemia and its potential mechanism. Chin. J. Mod. Appl. Pharm. 2020 37 1938 1946
    [Google Scholar]
  12. Xing N. Shu Z. Xu B. Jiao W. Wang Q. Kuang H. Isolation, purification, and structural elucidation of polysaccharide CALB-1 from Aurantii Fructus and study on its immunoregulatory activity. Chin. Herb. Med. 2015 46 639 644
    [Google Scholar]
  13. Jiang L. Tian X. Yuan Q. Liu J. Cui Q. Research progress on cultivation techniques of Citrus×aurantium ‘Changshanhuyou’ and chemical components and pharmacological action of Qu Aurantii Fructus. Zhejiang Linye Keji 2022 42 129 136
    [Google Scholar]
  14. Wu G. Characteristics and cultivation techniques of golden pomelo. South China Fruits 1987 01 16 18
    [Google Scholar]
  15. Xu C.J. Bao L. Zhang B. Bei Z.M. Ye X.Y. Zhang S.L. Chen K.S. Parentage analysis of huyou ( Citrus changshanensis ) based on internal transcribed spacer sequences. Plant Breed. 2006 125 5 519 522 10.1111/j.1439‑0523.2006.01263.x
    [Google Scholar]
  16. Zhao W. Huang Q. Zhang W. Yue C. Song J. Research for the original plant of chinese medicinal materials Qu Aurantii Fructus. Chin. J. Mod. Appl. Pharm. 2019 36 1652 1655
    [Google Scholar]
  17. Zhang Y. Song L. Liu S. Ruan L. Wang X. Song J. Wang L. Xu Q. Genetic identification of ‘Changshanhuyou’(Citrus × aurantium L.) of different ages and propagation types. Zhiwu Kexue Xuebao 2024 42 191 200
    [Google Scholar]
  18. Yue C. The Survey of Chemical components and Pharmacological effects in Citrus changshan-huyou Y.B.Chang. and to compared with Fructus aurantia. Zhejiang Chinese Medical University 2015
    [Google Scholar]
  19. Zhao X. Studies on chemical components and pharmacological and biological activities in Huyou peels (Citrus Changshan-huyou Y. B. Chang). Zhejiang University 2003
    [Google Scholar]
  20. Jiang L. Dong X. Tian Y. Song J. Zhao W. Hu Y. Li M. Feng J. Study on the material basis and mechanism of quzhiqiao’s hypoglycemic effect based on HPLC-Q-exactive orbitrap MS/MS integrated network pharmacology. Chin J Basic Med Tradit Chin Med 2024 30 461 467
    [Google Scholar]
  21. Sun Y. Wang J. Gu S. Liu Z. Zhang Y. Zhang X. Simultaneous determination of flavonoids in different parts of Citrus reticulata ‘Chachi’ fruit by high performance liquid chromatography-photodiode array detection. Molecules 2010 15 8 5378 5388 10.3390/molecules15085378 20714303
    [Google Scholar]
  22. Yan X. Yan Q. Liu X. Huang H. Zheng Z. Shi T. Determination of neohesperidin and naringin in quzhiqiao by high performance liquid chromatography. Food Res Dev 2018 39 161 166
    [Google Scholar]
  23. Yue C. Zhang W. Zheng C. Liang J. Song J. Chen B. Guo Z. Zhao W. Research on quality difference of Qu Aurantii Fructus and different Aurantii Fructus cultivars based on HPLC fingerprint. Chin. Herb. Med. 2024 55 2764 2770
    [Google Scholar]
  24. Chinese Pharmacopoeia Commission Pharmacopoeia of the People’s Republic of China 2020. Beijing China Medical Science Press 2020 1088
    [Google Scholar]
  25. Zhang H. Wang L. Wu Y. Bi X. Wang G. Zhao S. Xu C. Chen K. Fruit quality analysis and comprehensive evaluation of 18 Huyou (Citrus changshanensis) accessions. Guoshu Xuebao 2024 41 1033 1043
    [Google Scholar]
  26. Wang L. Zheng H. Xu X. Yang B. Liu C. Huang Z. Li H. Xu L. Effects of drying process of young fruits of Changshan Huyou(Citrus aurantium L.) on quality of qu fructus aurantii products. South China Fruits 2022 51 39 42
    [Google Scholar]
  27. Liu Z. Yan Z. Xu Y. Study on extraction of flavonoids from huyou peel with ultrasonic assist of surfactant. Food Res Dev 2020 41 125 130
    [Google Scholar]
  28. Serafini M. Peluso I. Raguzzini A. Flavonoids as anti-inflammatory agents. Proc. Nutr. Soc. 2010 69 3 273 278 10.1017/S002966511000162X 20569521
    [Google Scholar]
  29. Tan R. Meng J. Chen D. Jiao Q. Plant composition analysis. Science Press 2002
    [Google Scholar]
  30. Yu D. Wu J. Liu Y. Wang L. Yang X. Ye X. Chen S. Chen J. Analysis of main functional components in different parts of Citrus×aurantium L. Changshanhuyou fruits. J Zhejiang Univ Agric Life Sci 2023 49 802 812
    [Google Scholar]
  31. Gongyu H. China Books Publishing House 2010
  32. Li S. Dai Y. Zhao Y. Qin M. Research progress on distribution, biosynthesis and biological function of flavonoid C-glycosides. Res Pract Chin Med 2023 37 88 94
    [Google Scholar]
  33. Ohsugi T. Nishida R. Fukami H. Oviposition stimulant of Papilio xuthus, a Citrus-feeding swallowtail butterfly. Agric. Biol. Chem. 1985 49 6 1897 1900 10.1271/bbb1961.49.1897
    [Google Scholar]
  34. Song Y. Wang Y. Zhang C. Yang H. Study quality markers for blood lipid-lowering effect of Moringa oleifera leaves based on specific chromatogram, network pharmacology and multi-index quantitative analysis. Chin. Herb. Med. 2024 55 1686 1698
    [Google Scholar]
  35. Zhang Z. Zhao Q. Liu T. Zhao H. Wang R. Li H. Zhang Y. Shan L. He B. Wang X. Huang L. Hao D. Sun H. Effect of Vicenin-2 on ovariectomy-induced osteoporosis in rats. Biomed. Pharmacother. 2020 129 110474 10.1016/j.biopha.2020.110474 32768959
    [Google Scholar]
  36. Yan X. Liu X. Yan Q. Huang H. Shi T. Study on neohesperidin and naringin of quzhiqiao in Changshan different regions. Food Eng. 2019 04 40 43
    [Google Scholar]
  37. Fang J. Wu X. Jiang J. Mao L. Related analysis between antioxidant activities and HPLC fingerprint of flavonoids in citrus changshan-huyou Y.B. Peels. Chin. J. Mod. Appl. Pharm. 2018 35 1489 1493
    [Google Scholar]
  38. Zhao H. Liu M. Liu H. Suo R. Lu C. Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway. Biosci. Rep. 2020 40 3 BSR20193431 10.1042/BSR20193431 32091090
    [Google Scholar]
  39. Zhang J. Hui Y. Liu F. Yang Q. Lu Y. Chang Y. Liu Q. Ding Y. Neohesperidin protects angiotensin II-induced hypertension and vascular remodeling. Front. Pharmacol. 2022 13 890202 10.3389/fphar.2022.890202 35677431
    [Google Scholar]
  40. Liu Y. Niu L. Cui L. Hou X. Li J. Zhang X. Zhang M. Hesperetin inhibits rat coronary constriction by inhibiting Ca2+ influx and enhancing voltage-gated K+ channel currents of the myocytes. Eur. J. Pharmacol. 2014 735 193 201 10.1016/j.ejphar.2014.03.057 24751712
    [Google Scholar]
  41. Liu S. Gao X. Yin Y. Wang J. Dong K. Shi D. Wu X. Guo C. Silk fibroin peptide self-assembled nanofibers delivered naringenin to alleviate cisplatin-induced acute kidney injury by inhibiting mtDNA-cGAS-STING pathway. Food Chem. Toxicol. 2023 177 113844 10.1016/j.fct.2023.113844 37244599
    [Google Scholar]
  42. Velusamy P. Mohan T. Ravi D.B. Kishore Kumar S.N. Srinivasan A. Chakrapani L.N. Singh A. Varadharaj S. Kalaiselvi P. Targeting the Nrf2/ARE signalling pathway to mitigate isoproterenol-induced cardiac hypertrophy: Plausible role of hesperetin in redox homeostasis. Oxid. Med. Cell. Longev. 2020 2020 1 13 10.1155/2020/9568278 32952852
    [Google Scholar]
  43. Zhang M. Jing L. Wu Q. Zhu K. Ke F. Xu J. Zhao S. Wang G. Zhang C. Metabolite profile comparison of a graft chimera ‘Hongrou Huyou’ (Citrus changshan-huyou + Citrus unshiu) and its two donor plants. BMC Plant Biol. 2019 19 1 582 10.1186/s12870‑019‑2173‑4 31878871
    [Google Scholar]
  44. Lin Z.B. Contemporary Studies on Ganoderma lucidum. Beijing Peking Union Medical College and Beijing Medical University United Press 2001 219 220
    [Google Scholar]
  45. Luo J. Lin Z.B. Advances of pharmacological effects of triterpenes from Ganoderma lucidum. Yao Xue Xue Bao 2002 37 7 574 578 12914332
    [Google Scholar]
  46. Luo J. Sun Y. Li Q. Kong L. Research progress of meliaceous limonoids from 2011 to 2021. Nat. Prod. Rep. 2022 39 6 1325 1365 10.1039/D2NP00015F 35608367
    [Google Scholar]
  47. Jin S. Wang J. Chen S. Jiang A. Jiang M. Su Y. Yan W. Xu Y. Gong G. A novel limonin derivate modulates inflammatory response by suppressing the TLR4/NF-κB signalling pathway. Biomed. Pharmacother. 2018 100 501 508 10.1016/j.biopha.2018.02.046 29477914
    [Google Scholar]
  48. Li Y. Geng H. Li S. Analysis of the composition of essential oils from four citrus peels. Xiandai Shipin Keji 2019 35 264 272
    [Google Scholar]
  49. He D. Shan Y. Wu Y. Liu G. Chen B. Yao S. Simultaneous determination of flavanones, hydroxycinnamic acids and alkaloids in citrus fruits by HPLC-DAD–ESI/MS. Food Chem. 2011 127 2 880 885 10.1016/j.foodchem.2010.12.109 23140749
    [Google Scholar]
  50. Liu F. Huang Y. Yuan T. Zhang J. RP-HPLC determining the quantity of sypephrine in Fructus Aurantii. Hunan Guid. J Tradit Chin Med Pharmacol 2002 10 577 578
    [Google Scholar]
  51. Feng J. Song J. Zhao S. Xu L. Zhang W. Lei M. Study on spectrum-activity relationship of flavonoids in Qu Aurantii Fructus for regulation of gastrointestinal motility. Chin. J. Mod. Appl. Pharm. 2022 39 2241 2245
    [Google Scholar]
  52. Li G.J. Wu H.J. Wang Y. Hung W.L. Rouseff R.L. Determination of citrus juice coumarins, furanocoumarins and methoxylated flavones using solid phase extraction and HPLC with photodiode array and fluorescence detection. Food Chem. 2019 271 29 38 10.1016/j.foodchem.2018.07.130 30236679
    [Google Scholar]
  53. Luu H. Isomeranzin against Herpes simplex virus in vitro from Clausena heptaphylla (Roxb.) W. & ARN: Isolation, structure and biological assay. J Chem 2007 41 1 1 15
    [Google Scholar]
  54. Li L. Zhang S. Xin Y. Sun J. Xie F. Yang L. Chen Z. Chen H. Liu F. Xuan Y. You Z. Role of Quzhou Fructus Aurantii extract in preventing and treating acute lung injury and inflammation. Sci. Rep. 2018 8 1 1698 10.1038/s41598‑018‑20083‑z 29374248
    [Google Scholar]
  55. Li L. Chen J. Lin L. Pan G. Zhang S. Chen H. Zhang M. Xuan Y. Wang Y. You Z. Quzhou Fructus Aurantii extract suppresses inflammation via regulation of MAPK, NF-κB, and AMPK signaling pathway. Sci. Rep. 2020 10 1 1593 10.1038/s41598‑020‑58566‑7 32005962
    [Google Scholar]
  56. You Z. Zhang S. Qu X. Wu Y. Li Y. Wang Y. Zhang W. The invention relates to the effective composition group of Fructus aurantii for treating viral pneumonia, preparation method and application thereof. Patent CN113577088A, 2021
  57. Wu J. Huang G. Li Y. Li X. Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: Promising phytomedicines for the treatment of liver diseases. Chin. Med. 2020 15 1 89 10.1186/s13020‑020‑00371‑5 32863858
    [Google Scholar]
  58. Wang Y. Liu X.J. Chen J.B. Cao J.P. Li X. Sun C.D. Citrus flavonoids and their antioxidant evaluation. Crit. Rev. Food Sci. Nutr. 2022 62 14 3833 3854 10.1080/10408398.2020.1870035 33435726
    [Google Scholar]
  59. Zheng X. Liu C. Wang D. Bi X. Yang B. Sun C. Flavonoids contents and antioxidant activities in Citrus paradisi cv. Changshan Huyou during development. Acta Agriculturae Zhejiangensis 2015 27 1185 1191
    [Google Scholar]
  60. Zhang J. Sun C. Yan Y. Chen Q. Luo F. Zhu X. Li X. Chen K. Purification of naringin and neohesperidin from Huyou (Citrus changshanensis) fruit and their effects on glucose consumption in human HepG2 cells. Food Chem. 2012 135 3 1471 1478 10.1016/j.foodchem.2012.06.004 22953882
    [Google Scholar]
  61. Zheng H. Wang S. Zhong S. Lou L. Extract of Citrus Changshan-Huyou, ameliorates renal oxidative damage in type 2 diabetic db/db mice. Zhejiang J Integr Tradit Chin West Med 2020 30 105 108
    [Google Scholar]
  62. Rehman K. Munawar S.M. Akash M.S.H. Buabeid M.A. Chohan T.A. Tariq M. Jabeen K. Arafa E.S.A. Hesperidin improves insulin resistance via down-regulation of inflammatory responses: Biochemical analysis and in silico validation. PLoS One 2020 15 1 e0227637 10.1371/journal.pone.0227637 31929574
    [Google Scholar]
  63. Yan J. Nie Y. Xu S. Zhang S. Chen Z. Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p/NOXA2/NOX2 pathway. Phytomedicine 2023 118 154944 10.1016/j.phymed.2023.154944 37393830
    [Google Scholar]
  64. Slika H. Mansour H. Wehbe N. Nasser S.A. Iratni R. Nasrallah G. Shaito A. Ghaddar T. Kobeissy F. Eid A.H. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed. Pharmacother. 2022 146 112442 10.1016/j.biopha.2021.112442 35062053
    [Google Scholar]
  65. Li J. Wang T. Liu P. Yang F. Wang X. Zheng W. Sun W. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 2021 12 9 3898 3918 10.1039/D0FO02736G 33977953
    [Google Scholar]
  66. Liu X. Jiang X. Fang Y. Xia D. Wang S. Zhong S. Protective effect of total flavonoids from Fructus aurantii on lung injury of asthma mice infected with RSV through NF-κB signaling pathway. Zhejiang J Integr Tradit Chin West Med 2021 31 3376 3380
    [Google Scholar]
  67. Zhang Y. Lu P. Qin H. Zhang Y. Sun X. Song X. Liu J. Peng H. Liu Y. Nwafor E.O. Li J. Liu Z. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential. Biomed. Pharmacother. 2021 133 111072 10.1016/j.biopha.2020.111072 33378971
    [Google Scholar]
  68. Tan W. Li Y. Wang Y. Zhang Z. Wang T. Zhou Q. Wang X. Anti-coagulative and gastrointestinal motility regulative activities of Fructus Aurantii Immaturus and its effective fractions. Biomed. Pharmacother. 2017 90 244 252 10.1016/j.biopha.2017.03.060 28363170
    [Google Scholar]
  69. Hu Y. Chen H. Song Y. Tan S. Luo X. Yang W. Study on the mechanism of Aurantii Fructus Immaturus and its main active ingredients in promoting gastrointestinal motility of model rats with spleen deficiency. China Pharmacy 2017 28 1747 1750
    [Google Scholar]
  70. Ye Y. Hu S. Xu X. Yan F. Qin L. Zhu B. Determination and correlation analysis of four flavonoid glycosides in Fructus aurantii and its related species. Zhejiang J Integr Tradit Chin West Med 2022 32 752 755
    [Google Scholar]
  71. Liu C. Wang D. Bi X. Zheng X. Yang B. Sun C. Determination of flavonoid content and antioxidant activity of ethanol extract from Pomelo chinensis. South China Fruits 2015 44 41 44
    [Google Scholar]
  72. Wang L. Wang L. Wu T. Zhao S. Zheng M. Lu S. Effects of different processing methods on the contents of the pharmacodynamic index components and antioxidant activity of Citrus aurantium. China Pharmacy 2022 33 830 835
    [Google Scholar]
  73. Feng J. Hu W. Xu L. Li J. Wang S. Song J. Simultaneous determination of the contents of 12 flavonoids in Quzhiqiao from different collection places by HPLC. China Pharmacy 2020 31 571 575
    [Google Scholar]
  74. Li X. An Analysis of the Key Flavanone Componets and Their Content Variations in the Endemic Citrus Germplasm of China. Southwest University 2011
    [Google Scholar]
  75. Zhu X. Pan D. Comparative analysis of the contents of naringin, hesperidin and sypephrine in four kinds of Zhishi Chinese herbs. J Fujian Norm Univ 2005 01 91 93
    [Google Scholar]
  76. Ma Y. Chen H. Fang X. Wang X. Ge W. A comparative study on regulating qi effect of quzhiqiao (Fructus Aurantii from Zhejiang) and Fructus Aurantii from the other three major producing areas on functional dyspepsia rats. Chin J Tradit Med Sci Technol 2021 28 722 726
    [Google Scholar]
  77. Ge Y. Ma Y. Zhao M. Wei J. Wu X. Zhang Z. Yang H. Lei H. Wu B. Exploring gabosine and chlorogentisyl alcohol derivatives from a marine-derived fungus as EcGUS inhibitors with informatic assisted approaches. Eur. J. Med. Chem. 2022 242 114699 10.1016/j.ejmech.2022.114699 36001934
    [Google Scholar]
  78. Ge Y. Zhou C. Ma Y. Wang Z. Wang S. Wang W. Wu B. Advancing natural product discovery: A structure-oriented fractions screening platform for compound annotation and isolation. Anal. Chem. 2024 96 14 5399 5406 10.1021/acs.analchem.3c05057 38523322
    [Google Scholar]
  79. Sissi S. Loubna A. Ouhaddou S. Ahmed O. Larhsini M. Markouk M. In vitro antioxidant potential and in vivo analgesic and anti-inflammatory activities of Moroccan Equisetum ramosissimum. Nat. Prod. J. 2023 13 48 59
    [Google Scholar]
/content/journals/npj/10.2174/0122103155353712241008060527
Loading
/content/journals/npj/10.2174/0122103155353712241008060527
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keywords: Chinese herbal medicine ; citrus aurantiun ‘Changshanhuyou’ ; qu zhiqiao
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test